+Search query
-Structure paper
Title | Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8 H -purin-8-one Inhibitors of DNA-PK. |
---|---|
Journal, issue, pages | Acs Med. Chem. Lett., Vol. 13, Page 1295-1301, Year 2022 |
Publish date | Mar 10, 2022 (structure data deposition date) |
Authors | Goldberg, F.W. / Ting, A.K.T. / Beattie, D. / Lamont, G.M. / Fallan, C. / Finlay, M.R.V. / Williamson, B. / Schimpl, M. / Harmer, A.R. / Adeyemi, O.B. ...Goldberg, F.W. / Ting, A.K.T. / Beattie, D. / Lamont, G.M. / Fallan, C. / Finlay, M.R.V. / Williamson, B. / Schimpl, M. / Harmer, A.R. / Adeyemi, O.B. / Nordell, P. / Cronin, A.S. / Vazquez-Chantada, M. / Barratt, D. / Ramos-Montoya, A. / Cadogan, E.B. / Davies, B.R. |
External links | Acs Med. Chem. Lett. / PubMed:35978693 |
Methods | X-ray diffraction |
Resolution | 2.738 Å |
Structure data | PDB-7z61: |
Chemicals | ChemComp-IGJ: |
Source |
|
Keywords | SIGNALING PROTEIN / type I kinase inhibitor / structure-baed drug design |